These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4539549)

  • 1. [Action of clindamycin-2-phosphate and clindamycin-2-palmitate on the central nervous system].
    Yamazaki M; Tanabe K; Arima Y; Matsumoto Y; Kimijima K
    Jpn J Antibiot; 1972 Jun; 25(3):169-74. PubMed ID: 4539549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central nervous action of clindamycin].
    Tanabe K; Amano Y; Yamasaki M; Sakamoto T; Kimishima K
    Jpn J Antibiot; 1969 Aug; 22(4):303-7. PubMed ID: 5307757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological action of spectinomycin, with special reference to the action on central nervous system (author's transl)].
    Tamaki H; Kinoshita Y; Tanabe K; Yogi H; Gouen I
    Jpn J Antibiot; 1976 Jan; 29(1):30-5. PubMed ID: 131203
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological studies on the effects of Thalamonal, a neuroleptanalgesic, on the central nervous system].
    Sakai Y; Iwata N; Mori M; Nishijima Y
    Nihon Yakurigaku Zasshi; 1971 Sep; 46(5):431-51. PubMed ID: 5168892
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies on clindamycin-2-palmitate (author's transl)].
    Kono S; Onishi R; Yamanaka Y; Tateishi H; Aratani H
    Jpn J Antibiot; 1973 Aug; 26(4):325-33. PubMed ID: 4542668
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological testing of a new anti-inflammatory agent: 1-(m-trifluoromethylphenyl)-N-nitroso anthranilic acid].
    Zoni G; Molinari ML; Banfi S
    Farmaco Sci; 1971 Jun; 26(6):525-46. PubMed ID: 5561809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological studies on Gardneria alkaloids. I. Central effects].
    Harada M; Ozaki Y; Murayama S; Sakai S; Haginiwa J
    Yakugaku Zasshi; 1971 Sep; 91(9):997-1003. PubMed ID: 5167062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological studies on 5-hydroxy-L-tryptophan (L-5HTP). 1. Influence of L-5HTP on the central nervous system].
    Omori K; Orima H; Kojima T; Takahira H
    Nihon Yakurigaku Zasshi; 1973 Jul; 69(4):523-41. PubMed ID: 4546003
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies of 3',4'-dideoxykanamycin B].
    Koeda T; Shibata U; Asaoka H; Kabata Y; Yamaki Y
    Jpn J Antibiot; 1973 Feb; 26(1):28-39. PubMed ID: 4542395
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on josamycin propionate. VIII. Further pharmacological studies (author's transl)].
    Takagi T; Nozaki Y; Tachikawa S; Usuda S
    Jpn J Antibiot; 1974 Aug; 27(4):539-48. PubMed ID: 4474419
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of new tropine ethers with central activity.
    György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
    Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
    Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
    Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of the neuromuscular block produced by clindamycin and lincomycin.
    Wright JM; Collier B
    Can J Physiol Pharmacol; 1976 Dec; 54(6):937-44. PubMed ID: 191168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (5) Action of M73101 on the central nervous system (author's transl)].
    Sato M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):695-706. PubMed ID: 575516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of 4H-3-methylcarboxyamide-1,3-benzoxazine-2-one (F.I. 6654), a compound acting on the central nervous system.
    Suchowsky GK; Pegrassi L
    Arzneimittelforschung; 1969 Apr; 19(4):643-8. PubMed ID: 4977576
    [No Abstract]   [Full Text] [Related]  

  • 17. [New antibiotic, Josamycin. VII. Pharmacological study].
    Kuriaki K; Nozaki Y; Ida H; Kagami S; Odani Y
    Jpn J Antibiot; 1969 Jun; 22(3):232-41. PubMed ID: 4390288
    [No Abstract]   [Full Text] [Related]  

  • 18. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
    Kito G; Morimoto S; Shiomi M
    Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.